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SUMMARY
Open science is a new concept for the practice of experimental laboratory-based research, such as drug discovery. The
authors have recently gained experience in how to run such projects and here describe some straightforward steps othersmay
wish to take towardsmore openness in their own research programmes. Existing and inexpensive online tools can solvemany
challenges, while some psychological barriers to the free sharing of all data and ideas are more substantial.
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INTRODUCTION
Open Science is a way of practising science in
which all data and ideas are freely shared, anyone
may participate and there are no patents (Gowers
and Nielsen, 2009; Nielsen, 2011; Woelﬂe et al.
2011a,b; Reaves et al. 2012). It presents a number of
advantages over more traditional methods of carrying
out research, such as speed, involvement of a wide
network of experts with no prior contact with the core
team, robustness of solutions arising from continual
peer review, release of both positive and negative data
for reuse by others and a reduction in unnecessary
duplication of research worldwide.
The methodology of open science mimics the
open source movement in software development
that has achieved signiﬁcant commercial success
with products such as industry-leading web browsers
(e.g. Firefox) and operating systems (e.g. Linux).
Open science is, however, a new concept, and there is
some degree of variation in adherence to these core
principles (Årdal and Røttingen, 2012), and some
confusion with other, completely distinct, ideas such
as open innovation (Hunter and Stephens, 2010).
Open science has now been applied by us to drug
synthesis and drug discovery in the area of tropical
diseases (Woelﬂe et al. 2011a,b). This article de-
scribes lessons learned in the course of two speciﬁc
open projects, intended as a guide for those wishing
to employ similar methods in their own research.
Both projects carried with them the challenge of
being based in experimental science, i.e. where
physical objects had to be made, handled and shared.
For a non-experimental example of open science
in mathematics, see Gowers and Nielsen, 2009; for
excellent examples of crowdsourcing online see Land
et al. (2008) and Cooper et al. (2010).
The ﬁrst project involved the discovery of a way to
generate the chiral drug praziquantel (PZQ) as a
single enantiomer (Woelﬂe et al. 2011a,b). The
widespread use of PZQ is hampered by side eﬀects
and a bitter taste caused by the distomer (Meyer et al.
2009). A strategic goal of the Special Programme for
Research and Training in Tropical Diseases (TDR)
of the World Health Organisation had been to
perform a ‘chiral switch’ on PZQ that would result
in a pill containing the (R)-enantiomer while keeping
the price low. An open approach to this project was
started in 2006, but a funded kernel of eﬀort began in
the laboratory in January 2010. The inputs of the
broader community led to both changes in direction
of the research and an acceleration of the science,
leading to the publication in 2011 of a solution to the
problem suitable for scale-up.
While this was an important proof-of-concept, it
begged the question of whether similar ideas could
be applied to drug discovery, where the intellectual
property landscape is more complicated, and the
long-term funding regime less clear; such an idea
had been mooted or started but a full campaign
never tried (Maurer et al. 2004; Bradley et al. 2008).
There have been major moves to make the drug
discovery process more collaborative, such as via
Product Development Partnerships like the
Medicines for Malaria Venture (MMV) and the
Drugs for Neglected Diseases Initiative (DNDi) or
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other ventures (Norman et al. 2011). The sharing of
chemical compounds to stimulate research in malaria
and other neglected diseases (the ‘Malaria Box’) has
even been pioneered by (MMV Spangenberg et al.
2013).
An open source drug discovery consortium in
malaria was begun and is now in the second year of
its existence (http://opensourcemalaria.org). It is
currently centred in Sydney (Australia) but has
involvement from various laboratories around the
world, including links to a group with similar ideals
in India that has to date focused more on tuberculosis
chemo- and bioinformatics (Bhardwaj et al. 2011;
http://malaria.osdd.net/). The aim of the project is to
take hits (molecules with some cellular activity) such
as those placed in the public domain from the
GlaxoSmithKline Tres Cantos phenotypic screen
(Gamo et al. 2010) and prosecute a drug discovery
project with the aim of generating a compound
entering Phase I clinical trials.
These two projects are centred on basic exper-
imental scientiﬁc research, in that the same day-
to-day questions are being asked, and the same
theoretical approaches (e.g. general medicinal chem-
istry methods) are followed as for regular research
projects. It is rather the shift to working entirely in
the public domain that is so radical and, it turns
out, productive. This article is an ‘under-the-hood’
description of how such projects function, intended
for those considering a move towards open source
science, but who are unsure how such projects can
work. Before turning to the details it is important ﬁrst
to be clear on the philosophy that underpins open
science. This philosophy was formulated during
the PZQ project, and true to form has been in the
public domain since the start of the malaria project,
stated as Six Laws (http://www.thesynapticleap.org/
node/343):
First Law: All data are open and all ideas are
shared;
Second Law: Anyone can take part at any level of
the project;
Third Law: There will be no patents;
Fourth Law: Suggestions are the best form of
criticism;
Fifth Law: Public discussion is much more
valuable than private email;
Sixth Law: The project is bigger than, and is not
owned by, any given laboratory.
Should any of these principles be unacceptable, it
would be advisable to steer clear of open science in
practice. While these laws may be an initial psycho-
logical/organizational/legal challenge, it has been
found that there are simple practical steps that anyone
may take to work in this way that require zero capital
investment.
DISCUSSION
Methodology of open research
Electronic laboratory notebook. The bedrock of an
open project is a means to share all primary data. This
requires that the laboratory notebook moves
from paper to digital and from the benchtop to the
internet. While there are many commercial electronic
laboratory notebooks (ELNs) we have to date
adopted an open source ELN because we did not
want to rely on the commercial health of an
organization for the survival of the data, and because
it was important that potential future collaborators
(particularly from developing nations) would not
need to purchase software in order to participate. The
solution we chose (Labtrove, Fig. 1; http://www.
labtrove.org/) may be downloaded and installed
locally; as an open source product Labtrove may
be modiﬁed and the modiﬁed code may be made
freely available to the community, as one of us has
already done (Modtrove: https://github.com/miike/
modtrove).
Each researcher can maintain a separate note-
book within a project, or laboratory notebooks can be
shared. The ELN should be kept like a regular
laboratory notebook, including for the posting of
hazard assessments and authorizations. It is simple to
maintain links between related experiments and links
to relevant primary literature. Raw data can be posted
alongside human-readable processed versions of data,
meaning that all data are maintained in one place and
backed up. The ELN provides permanent links
to individual experiments that may be used in papers
to refer to research on an experiment-by-experiment
basis (Woelﬂe et al. 2011b). All changes to the
ELN are recorded and automatically time-stamped
(a current and signiﬁcant weakness of paper labora-
tory notebooks). To reduce the barrier to partici-
pation, login (required if one wishes to comment on
another’s work) is simple via a number of common
authentication mechanisms but is not necessary to
read the content.
We have found the ability to post images has been
beneﬁcial in terms of encouraging reproducibility.
Images are also inserted to illustrate chemical re-
actions or structures. Tables of data may be inserted,
but they currently lack spreadsheet functionality
that would be useful for trivial calculations. Required
improvements to the software like this can be sub-
mitted to the community as a feature request for
future releases.
The ELN itself may be searched, but to ensure the
maximum discoverability of the notebook itself by
people outside the project it is important that the
content is understood by search engines. In the case
of molecules, machine-readable text-strings (using
the SMILEs or InChI systems, that are easy to
generate) (Southan, 2013) can be inserted manually
in ELN entries.
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A more detailed description of this online elec-
tronic laboratory notebook will shortly be published
elsewhere. It should be emphasised that the depo-
sition of all primary data is the one central element to
any open science endeavour, without which a truly
collaborative eﬀort will not function. Not least, the
availability of raw data permits objective quality
control of all contributions.
Data management. The primary data generated in
the open source drug discovery for malaria project
consist of structures with physical and biological
properties. In a closed project, one might keep such
data in a spreadsheet or electronic database, but when
the data are to be shared, and remain modiﬁable by
the community, this is not so straightforward. We
found that a widely-used online spreadsheet appli-
cation (Google Docs) was adequate for smaller sheets
of data, but found the system strained when it was
required to retrieve images of multiple molecular
structures in the course of loading. Ultimately, we
adopted an approach borrowed from the open source
software movement where sophisticated websites
exist for management of coding projects and which
are suitable for management of communal data,
in this case an SD ﬁle that contains all chemical
information and may be downloaded, modiﬁed and
re-uploaded (Fig. 2). (Ram, 2013; https://github.
com/OpenSourceMalaria/OSM_compounds) The ﬁle
is discoverable by search engines.
Local data management for the project is necess-
ary, but in the longer term the data need to be
maximally discoverable and searchable, meaning
they should be curated to a level that is probably
best left to specialists and, in the case of the malaria
project, the data have been batch-uploaded to the
chemical informatics database of the European
Molecular Biology Laboratory, ChEMBL (Fig. 3)
(https://www.ebi.ac.uk/chembl/malaria/doc/inspect/
CHEMBL2113921; Avery et al. 2013). Besides the
presentation of data in the most useable format, the
dataset itself gains permanence, for example via a
Digital Object Identiﬁer (DOI). In future a more
automated approach to feeding data from local to
larger databases will be needed. There are other tools
we have not employed that others might ﬁnd valuable
Fig. 1. A sample page from an electronic lab notebook created with the open source software, Labtrove.
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for the sharing of chemical and biological data
(e.g. Figshare, Dryad, Pubchem, ChemSpider and
other non-proﬁt/commercial databases) or places
where the data might usefully be incorporated (e.g.
OpenPhacts). There are also valuable tools to prompt
the machine discovery of chemical information in
web pages that can then feed into the aforementioned
resources (e.g. Chemicalize).
Beyond primary data – coordination tools. Scientiﬁc
research happens in a variety of ways beyond the
laboratory notebook, and it is important for open
projects to capture not just data and workﬂow but
strategy. The primary means of doing this is to post
project updates on a more familiar blogging environ-
ment that allows input by others with a low barrier to
entry. The Synaptic Leap website (http://www.
thesynapticleap.org/) fulﬁls this role as a coordination
space and is built on the popular open source
standard known as Drupal, but any blogging plat-
form would suﬃce here as a ﬁrst approximation. A
website like this also functions as a marketing tool, to
act as a central place people can remember to go for
the latest updates. More widely, a function of the
central blog can be to allow anyone to run their own
open science projects, as is the case in The Synaptic
Leap.
Project updates act as a means to distil results in
smaller units than a full write up in a paper, while also
bringing people new to the project up to speed.
Updates are written by the researcher who did the
work, not necessarily the person in charge of the
project. Users of the coordination site can post via an
account name or anonymously. Conducting science
Fig. 2. Management of updatable data ﬁles using existing software designed for managing coding projects.
Fig. 3. Deposition of data in openly-available online databases enhances discoverability.
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in this way has a democratising or levelling eﬀect that
undercuts the traditional academic monikers – thus
for example in comments under a post in the malaria
project (Fig. 4) (http://www.thesynapticleap.org/
node/367) an undergraduate student and a professor
who had nevermet were able to discuss openly a point
of theory about the data without it ever mattering
who was who.
Active coordination like this is important, but
many blog posts become out of date and are intended
mainly for temporary consultations. It is useful to
maintain one continually updated page that describes
project status – a page that does not grow linearly, but
is changed only in response to achievements. A wiki
can be useful for this and there are many suitable
providers, such as OpenWetWare, used in both our
current projects. Ease of use is slightly lower than for
a blog, and there is much less visible discussion on a
wiki, but for the core team of a project this is a simple
way to update key discoveries and to provide one page
that newcomers can be directed to that describes the
history of the project. The malaria project’s ‘Story-
so-Far’ page (Fig. 5) (http://openwetware.org/wiki/
OpenSourceMalaria:Story_so_far) has to date been
visited around six thousand times. A wiki can also be
a useful place to draft papers collaboratively, owing to
most wiki sitesmaintaining revision histories, records
of provenance of contributions and a ‘talk’ page
where geographically separated contributors can
address what needs to be written. There will,
however, come a point where the paper needs to be
adapted to the usual requirements for submission to a
journal for peer review, and typically this will require
lengthy formatting changes, e.g. in theway references
are handled, that slightly reduces the usefulness of
wikis in this role. Academic theses, should they arise
from the project, can be shared in the public domain
via a number of means such as University reposi-
tories or other services, and may gain signiﬁcant
exposure as a result (Cronshaw, 2012).
Tools to enhance community input. An open project
requires momentum to be successful and this
momentum is provided by participants who can
arise from the core team or from the wider commu-
nity. Those in the wider community can become
involved only if they know of the project’s existence.
It is thus important to publicise what is happening on
the project, and this means posting updates, ques-
tions or requests for help in places where people
gather. It also means detailed public discussion of
the project before publication, one of the most serious
psychological barriers to many scientists in tra-
ditional disciplines, yet one of the most obvious
steps to those with a background in software
development.
For our projects, we have found that various freely-
available tools provide new and useful functionality
for the coordination of experimental science. One
of the most promising recent additions has been
Google+ (Fig. 6), which hosts pages or groups for
project-speciﬁc discussions, allows the simple post-
ing of pictures or event invitations to meetings, and is
a platform with a large pre-existing public user base.
Other popular social networking platforms could
also fulﬁl this role. It was found in the PZQ project
that a more focused professional networking site
(LinkedIn) was a productive way to reach a special-
ised target audience, since there are groups there with
speciﬁc focus on areas such as process chemistry or
medicinal chemistry; it helps if these groups are open,
as opposed to members-only. These sites can be
useful for short-term pushes to solve small problems;
the discussion lasts only for a short time since activity
Fig. 4. The Synaptic Leap, a coordination site allowing project discussion and updates.
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Fig. 5. A project wiki can act as a project status page.
Fig. 6. Example Google+ post in the open source drug discovery for malaria project.
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becomes buried quickly by newer items and only
those people who originally participated in a discus-
sion will be alerted to future posts. If a speciﬁc issue is
identiﬁed, and if others can engage through provid-
ing ‘microcontributions’ then signiﬁcant successes
can be achieved in the short term. It should be
stressed that these platforms are being run by
commercial organizations with no guarantee of
long-term survival; one lives with the risk of platform
collapse in the future, while gaining the beneﬁt of a
large user base that would otherwise be diﬃcult to
generate.
For the community to be able to help in guiding
the research through timely inputs, it is important
they are aware of where the project is headed in the
long (e.g. month-quarter) term. Their participation
in online project meetings is desirable, and may be
achieved to some extent with freely available tele-
conferencing tools (e.g. Skype, Google Hangout) but
this is one area where we have resorted to a
commercial solution which minimises latency during
the meeting, permits multiple participants from
diverse time-zones and allows the recording of the
meeting (Adobe Connect). The recording should be
used for the creation of meeting minutes that are
posted online alongside the recording (e.g. on
popular sites such as YouTube). The use of blogs
has proven to be successful in generating valuable
suggestions and discussions here. It is important that
an open project is seen to be responsive to this varied
input. It is also important that key strategies for the
research period following any meetings are clearly
decided and described; this opportunity to agree
future strategy collectively has been a particular
beneﬁt of online project meetings in terms of
maintaining focus and momentum.
Smaller project alerts can bemanaged with popular
platforms (such as Twitter) (https://twitter.com/
O_S_M), for example in the posting of a link to a
new project update, or the asking of a short question.
Again, the power of such platforms for generating
help with a certain project-related issue lies in their
popularity, rather than in their perceived academic
rigour. As with any such site we have found it is
important for the updates to be human-derived
(interactive) rather than made in broadcast mode by
a feed or a machine – i.e. should you ask a question of
the community, it is both good manners and more
productive if there is a human being ready to interact
with the responses.
Miscellaneous. Other tools exist that might become
useful to open projects, but which we have not used
extensively to date. Collaborative management of
references is possible (e.g. with Mendeley), colla-
borative discussion of scientiﬁc problems is possible
on a number of platforms (e.g. ResearchGate) and
there is work underway to aggregate topic-speciﬁc
scientiﬁc content from the internet (Ekins et al.
2012). There are sites known to be eﬀective in
community problem solving in software develop-
ment (e.g. Stackoverﬂow) that have created sophis-
ticatedmetrics for measurement of contributions that
have not yet impacted signiﬁcantly on the workﬂow
of open science projects. The manipulation of data
between formats will become challenging once a
dataset becomes large, and will eventually begin to
require specialist tools, for which there are robust
open source solutions (e.g. Knime); much of this
activity will be served by valuable emerging open
standards for data (O’Boyle et al. 2011).
The management of physical samples is an inter-
esting challenge for experimental open science.
In some senses this is a straightforward problem:
regular mail and courier services are adequate for
movement of samples. But in a broader sense, the
global management of physical objects in a pro-
ductive manner is a huge unsolved problem. If one
thinks of the number of samples of molecules
contained in fridges and freezers of industrial and
academic laboratories worldwide, one realises there
is a great untapped resource that could have a
signiﬁcant impact on open science projects with the
provision of eﬀective information management. For
example, Synthetic Laboratory A may possess a
collection of unpublished molecules structurally
similar to a hit molecule of great interest to
Medicinal Chemistry Laboratory B. Thesemolecules
may all be ineﬀective but at least Laboratory B would
not need to spend time on laborious resynthesis if it
knew of Laboratory A’s compound archive. All that is
required to transform this situation, besides the shift
to a more open mindset, is suitable coordination of
these samples to match needs with supply, and a
great deal of scientiﬁc progress could be made
with greater eﬃciency –what one of us termed the
‘Molecular Craigslist’ problem (http://intermolecular.
wordpress.com/2012/04/20/molecular-craigslist/).
Origin of contributions. With all these tools in place,
and once an open project is generating data, is it
reasonable to expect people to contribute? Based on
our recent experience, and the truly enormous eﬀorts
in open source software development worldwide, the
answer is yes. One should not expect to need
thousands of participants for a project – a handful of
motivated, knowledgeable participants, particularly
those able to contribute experimental resources, can
make a big diﬀerence.Wheremight one expect to ﬁnd
such help and contributions? This is not easy to
predict. With a regular ﬂow of experimental data,
regular project updates, a clear identiﬁcation of the
needs of a project that is helpfully split into small
tasks, help might appear from anywhere. With a clear
incentivization (authorship, community acclaim or
good public relations) and a low barrier to entry, it is
simple for potential contributors to act in their own
interests and contribute. Inputs from industry, for
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example, might be expected for selﬁsh reasons of
good public relations or demonstration of core
technical competence to potential future clients. As
the move towards greater openness starts to take hold
in science, the pool of interested contributors should
grow, as should the ease of ﬁnding the most relevant
people or, more importantly, the ease with which
suitable experts can ﬁnd open projects on which they
can have an impact.
What’s missing? After several years of assessment of
how to run experimental open science projects, it is
clear to the authors that while there are many useful
tools that permit science to be carried out produc-
tively in this way, still there are many important
components lacking. Some of these relate to
logistics, i.e. how to manage distributed projects.
The tools available allow a project to get oﬀ the
ground, but they are not yet ideal. For example, the
ELN we have employed lacks several features,
ranging from the simple (eﬀective notiﬁcations of
comments on entries) to the complex (the impossi-
bility of drawing and editing a chemical structure on
a webpage). It is important to keep the action items
of what is currently needed clearly visible on a
project ‘Landing Page’ where fresh content is placed
automatically – a current need for the malaria
project (Note added in proof: this page now exists
[http://opensourcemalaria.org]). The creation of
new entries on our Synaptic Leap blogging plat-
form has been an issue, due to the eccentric abilities
of the site to handle images and formatting; these can
usually be overcome, but if one presents a barrier
to project entry like this one can expect mildly
enthusiastic people to drift away or to clog up the
project mechanism by requesting core teammembers
to troubleshoot others’ entries. One of the key
advantages of using open source software for such
projects is that the software can be adapted by
the community as the needs of the open science
projects become clearer and more sophisticated in the
future.
The stability of the scientiﬁc record increasingly
depends on the longevity of web-based resources
(Schultheiss et al. 2011). While a diversity of web-
sites can fulﬁl diﬀerent project roles, as the project
grows so does the number of ‘dead’ links that have
not been adequately updated to reﬂect project
progress. Those wishing to run open projects must
commit time and resources to the management of
websites.
Speciﬁcally with regards to chemical synthesis and
biological evaluation, there is an issue of users outside
the project ﬁnding the relevant science. Asmentioned
above, chemical content can be manually added to
web pages through text strings, or through manual
prompting of online tools, but it is clearly going to
be important for chemical content to be retrieved,
understood and managed across the web by machines
in the generation of freely-available databases.
Though this remains a daunting problem, the
beneﬁt would be enormous, since this would create
an internet that could inform the chemical reader
who is working on related chemistry or compounds
at the present moment, rather than once an article
appears in the academic literature many months
later.
An issue remains that is relevant to the
psychology of participants too. There are concerns
about working in the public domain, ranging
from the embarrassment of being wrong, through to
a concern that preliminary data could be taken as
‘ﬁnal’ or ‘conﬁrmed’ data. There is thus a typical
desire to interact, particularly by newcomers, by
email, which generates a closed line of communi-
cation that often then needs to be converted to one
in the public domain. It is the authors’ opinion
that such concerns and practices will diminish,
but these will certainly require careful management
by anyone considering starting a scientiﬁc project
in the public gaze. Researchers will also obviously
need to clarify, and possibly challenge, the
default practices of their employers regarding any
intellectual property implications of the work being
pursued.
Residual questions
Will I get scooped? Possibly. If that can happen in a
short timeframe, it might be time to select another
research problem. However, one should realise that
open deposition of results on a webpage (backed up
by primary research data) is the quickest dissemina-
tion mechanism possible. Though not without risk,
this may favour the junior academic who is willing to
experiment with new dissemination methods.
Authors attempting to scoop your work then need
to acknowledge your prior art. Those authors could
claim ignorance of your work; this is diﬃcult to prove
or disprove, but with the power of current search
engines, and their ubiquitous use, such a claim is
weakening.
Participants in an open project should hope that
their work is widely read, and widely used by others.
The licence adopted should therefore be clearly
stated somewhere on each online resource. Readers
are directed to valuable resources describing the
licences that could be considered for open endeavours
(http://pantonprinciples.org/; Williams et al. 2012;
Wilbanks 2013); a Creative Commons CC-BY
licence (http://creativecommons.org/licenses/by/3.0/)
was adopted in both projects described in this article
and serves the purpose well – in essence the licence
states that others may use any part of the project in
their own work, even to make money, provided the
open projects are cited. This promotes reuse of the
data and ideas of a project (including to stimulate
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commercial activity) while maintaining proper aca-
demic standards of attribution.
If I release everything, surely that prevents commercia-
lization of my work? Possibly (Caulﬁeld et al. 2012).
The lack of a clear answer on this issue was one of
the major drivers in setting up the open source
malaria consortium in the ﬁrst place. Open source
software underpins technologies of enormous com-
mercial signiﬁcance, many of which are trademarked
or copyrighted, rather than patented. To the speciﬁc
assertion of whether a patent is needed to create a
drug, space does not permit a proper answer to this
interesting question, but powerful arguments against
the need for patents have already been published by
others (Boldrin and Levine, 2008). The arguments
may alter depending on a drug development candi-
date’s Net Present Value, i.e. the net costs of
developing vs selling the drug (DiMasi et al. 2003;
Svennebring and Wikberg, 2013). However, clearly
much of the basic science that underpins drug
discovery is amenable to an open approach (with a
prominent example being the open access chemical
probes developed by the Structural Genomics
Consortium) (Edwards et al. 2009).
How do I publish open science? Many journals are
now open access or provide open access options, and
these obviously need to be used in order to prevent a
total philosophical own-goal. However, many such
journals will also accept research that has already
appeared in the public domain – for example the PZQ
project (Woelﬂe et al. 2011b) was published in a high-
impact open access journal despite all the data having
been deposited in openly available ELNs. A peer-
reviewed research paper plays a crucial role as a
summary of an open project, upon the reaching of a
certain milestone. The journal article is important
since it is cited, permanent and a declaration by the
open project that part of the research is complete, and
has been peer-reviewed. Publishing in the traditional
way remains an important component of reputation
building for junior scientists and career development
for senior scientists. The mechanism of publishing
in open access journals may depend on the funding
agency supporting the work, or the country of
residence of the corresponding author, and any
associated costs will need to be factored into the
project plan at the outset. An intriguing possibility to
promote the practice of open science might be for
publishers to discount the fees associated with such
projects.
How do I fund an open science project? If this all
sounds like an attractive and productive way to
work, the ﬁnal issue is how to get it funded. The
tools above can be adopted with virtually zero
capital investment, and many research organizations
should be willing to provide the modest IT support
necessary to run the infrastructure (e.g. a server for
the ELN, and some guarantee of data backup).
Salaries for those driving the core of a project would
helpwith that project’smomentum, but openprojects
ﬂourish because of the contributions of others, and
these can arise from people in a wide variety of
circumstances, ranging from research professionals
contributing because the project aligns with their
core intellectual or commercial interests, through to
students contributing in their spare time.
It is the authors’ belief that research is moving
towards a more open era, and that it will become
increasingly diﬃcult to justify research in basic
science that does not attempt to make an eﬀort to
involve extra research expertise from around the
world, to publish negative data, to ensure maximum
data reuse and to avoid unnecessary duplication of
eﬀort. Funding agencies should see the added value
of funding a project kernel to which others, not
funded by the core grant, can contribute. Beyond
mandating open access to research papers, such
agencies should be aware of the extra downstream
beneﬁts of open data stimulating further research
outputs (Royal Society, 2012). This is perhaps best
exempliﬁed by the Human Genome Project, where
the costs of the project are dwarfed by the down-
stream economic impact of the open data produced
(Battelle, 2011). Beyond open data lies open source,
where participants may help guide and improve the
research itself before it is carried out – the subject of
this article.
The kernel funding for the two open projects de-
scribed above arose from a combination of industry/
NGO funds matched with government funding.
An open source project is a highly distributed and
mobile research project, in which people give time
and resources when it suits them, but the compo-
sition of the team constantly changes. There are
therefore few ‘start-up’ costs to get the project team
moving since resources that currently exist will be
employed, and should unplanned needs arise, new
contributors can be brought in for small contri-
butions without the requirement for long-term
commitments. This creates a ‘nimble’ team that can
adapt quickly to changes, and which can be broader
than the circle of acquaintances of the chief investi-
gators. Again, though this can represent something of
a challenge to the traditional management structure
of a research project, the beneﬁts have, in our
experience, more than compensated and can be
proposed in grant applications.
Readers are welcome to contact the authors to
discuss any aspects of running open science projects
along the lines described above. Avoidance of
bilateral channels such as email would be much
appreciated. (The corresponding author for example
can be reached on Google+ through a search of his
name, or on Twitter at @mattoddchem).
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